References
1. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births:
Final Data for 2016. Natl Vital Stat Rep 2018;67: 1-55.
2. ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod
2000;15: 1856-64.
3. Harbottle S, Hughes C, Cutting R, Roberts S, Brison D. Elective
Single Embryo Transfer: an update to UK Best Practice Guidelines. Human
Fertility 2015;18: 165-83.
4. American Society for Reproductive Medicine. Elective single-embryo
transfer. Fertil Steril 2012;97: 835-42.
5. Evans MI, Ciorica D, Britt DW, Fletcher JC. Update on selective
reduction. Prenat Diagn 2005;25: 807-13.
6. Obican S, Brock C, Berkowitz R, Wapner RJ. Multifetal Pregnancy
Reduction. Clin Obstet Gynecol 2015;58: 574-84.
7. Papageorghiou AT, Avgidou K, Bakoulas V, Sebire NJ, Nicolaides KH.
Risks of miscarriage and early preterm birth in trichorionic triplet
pregnancies with embryo reduction versus expectant management: new data
and systematic review. Hum Reprod 2006;21: 1912-7.
8. Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal
growth: a sonographic weight standard. Radiology 1991;181: 129-33.
9. Zeger SL, Liang KY. Longitudinal data analysis for discrete and
continuous outcomes. Biometrics 1986;42: 121-30.
10. Antsaklis A, Souka AP, Daskalakis G, Papantoniou N, Koutra P,
Kavalakis Y, Mesogitis S. Embryo reduction versus expectant management
in triplet pregnancies. J Matern Fetal Neonatal Med 2004;16: 219-22.
11. Shiva M, Mohammadi Yeganeh L, Mirzaagha E, Chehrazi M, Bagheri
Lankarani N. Comparison of the outcomes between reduced and nonreduced
triplet pregnancies achieved by Assisted Reproductive Technology. Aust N
Z J Obstet Gynaecol 2014;54: 424-7.
12. Anthoulakis C, Dagklis T, Mamopoulos A, Athanasiadis A. Risks of
miscarriage or preterm delivery in trichorionic and dichorionic triplet
pregnancies with embryo reduction versus expectant management: a
systematic review and meta-analysis. Hum Reprod 2017;32: 1351-9.
13. Chaveeva P, Kosinski P, Puglia D, Poon LC, Nicolaides KH.
Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: outcome
after embryo reduction compared to expectant management. Fetal Diagn
Ther 2013;34: 199-205.
14. Drugan A, Ulanovsky I, Burke Y, Blazer S, Weissman A. Fetal
reduction in triplet gestations: twins still fare better. Isr Med Assoc
J 2013;15: 745-7.
15. Ata B, Rasillo LJ, Sukhdeo S, Son WY, Tan SL, Dahan MH. Obstetric
outcomes of IVF trichorionic triamniotic triplets which are
spontaneously or electively reduced to twins. J Assist Reprod Genet
2011;28: 1217-22.
16. Skiadas CC, Missmer SA, Benson CB, Acker D, Racowsky C. Spontaneous
reduction before 12 weeks’ gestation and selective reduction similarly
extend time to delivery in in vitro fertilization of
trichorionic-triamniotic triplets. Fertil Steril 2011;95: 596-9.
17. Stone J, Ferrara L, Kamrath J, Getrajdman J, Berkowitz R, Moshier E,
Eddleman K. Contemporary outcomes with the latest 1000 cases of
multifetal pregnancy reduction (MPR). Am J Obstet Gynecol 2008;199: 406
e401-4.
18. Evans MI, Andriole S, Britt DW. Fetal reduction: 25 years’
experience. Fetal Diagn Ther 2014;35: 69-82.
19. Bakker M, Birnie E, Robles de Medina P, Sollie KM, Pajkrt E, Bilardo
CM. Total pregnancy loss after chorionic villus sampling and
amniocentesis: a cohort study. Ultrasound Obstet Gynecol 2017;49:
599-606.
20. Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and
cerebral palsy in births in Western Australia in the 1980s. BMJ
1993;307: 1239-43.
21. Pharoah PO, Cooke T. Cerebral palsy and multiple births. Arch Dis
Child Fetal Neonatal Ed 1996;75: F174-7.
22. Yokoyama Y, Shimizu T, Hayakawa K. Prevalence of cerebral palsy in
twins, triplets and quadruplets. Int J Epidemiol 1995;24: 943-8.
23. Dimitriou G, Pharoah PO, Nicolaides KH, Greenough A. Cerebral palsy
in triplet pregnancies with and without iatrogenic reduction. Eur J
Pediatr 2004;163: 449-51.
24. Wadhawan R, Oh W, Vohr BR, Wrage L, Das A, Bell EF, Laptook AR,
Shankaran S, Stoll BJ, Walsh MC et al. Neurodevelopmental outcomes of
triplets or higher-order extremely low birth weight infants. Pediatrics
2011;127: e654-60.
25. Chollat C, Sentilhes L, Marret S. Fetal Neuroprotection by Magnesium
Sulfate: From Translational Research to Clinical Application. Frontiers
in neurology 2018;9: 247.
26. Crowther CA, Hiller JE, Doyle LW, Haslam RR, Australasian
Collaborative Trial of Magnesium Sulphate Collaborative G. Effect of
magnesium sulfate given for neuroprotection before preterm birth: a
randomized controlled trial. JAMA 2003;290: 2669-76.
Table 1. Clinical characteristics of the study population